# Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.

> **NCT02396966** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 152 (actual)

## Conditions studied

- Acromegaly

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02396966
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2018-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02396966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02396966, "Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide Autogel® Treatment.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02396966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*